Groowe Groowe / Newsroom / BIIB
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BIIB News

Biogen Inc. Common Stock

Biogen and Stoke Therapeutics Present Data that Further Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 2025 American Epilepsy Society (AES) Annual Meeting

globenewswire.com
BIIB STOK

Companion Diagnostics Market Research 2025: $21+ Bn Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2024-2034

globenewswire.com
PFE MRK AZN TMO ABT AMGN JNJ BMY LLY MYGN GRDX BIIB BDX

Vertero Appoints Jeffrey Kasten as Chief Business Officer

globenewswire.com
BIIB

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025

globenewswire.com
BIIB

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025

prnewswire.com
BIIB

Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight

prnewswire.com
NVO ULTX SGMO PFE BMN SNY CHGC RHHBY ALNY BIIB BAY TSEM CSL HEMA LFB OCT SOBI ASC

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

globenewswire.com
PFE NVO AGIO FCRX BLUE ALXN Takeda REGN BEAM EDIT SANG SRPT CRSP XENE GILD AMGN BMRA BIIB ACRX AZN SNY ROCHE CSL SANA INVO VRTX ABBV LLY JNJ MRK BMY MDCO PTLA RHHBY BCLI CELG NBIX ALNY SPRC ACST ADPT AMTX APLS ARNA ATRC AVEO AXSM BPMC CDMO CLVS CNCE CRBP CTIC CYTK DFFN DOCU DRNA DTIL EARS EBAY ECHO EGRX ENDP ENZ EPZM ESRX EXAS FGEN FMI FRPT FTNT GALT GENE GNTX GRFS GSK HALO HAYW HBMD HGEN HLTH HPE HTGM ICPT IDXX ILMN IMCR IMNX INCY IND INTC INTU IOVA IRTC ISRG ITCI JAZZ KDP KHC KODK LAKE LULU LPTX LSCC LX LYFT MARA MCRB MDLZ MED MELI MGM MITK MLNX MNST MRVL MSFT MTCH MU MXIM MYL NCLH NDSN NET NEWM NFLX NKE NOC NOV NTES NVDA NXPI OBLN OC ODFL OLED OMER ON ONDK ORCL ORGN OSUR OTIS OXBR PACB PANW PAYX PCAR PCG PDD PEGA PEP PGR PGRD PHG PI PINS PLAB PLAY PLRX PM PNRA PPC PPD PRGS PRGO PRKR PRO PRTA PSN PTC PTCT PTON PUBG PVH QCOM QGEN QLGN QLYS QTRX RARE RCL RDNT REMY RFMD RGEN RH RIBT RIG RLAY RMBS RMD ROST RPTP RS RSP RTX RUN RVMD RYAAY SAGE SAN SBAC SBEA SCLX SCWX SD SE SEIC SELB SGEN SGH SHCR SHPG SI SIRI SITE SIVB SKX SLAB SLGN SMCI SMMR SMPL SNBR SNOW SOFI SOL SONO SOUN SPCE SPG SPLK SPOT SQ SQM SRDX SSYS ST STAG STAR STCN STLD STNG STOK STOR STX SUMO SWAV SWCH SWKS SYK SYMC SYNH SYRS T TAL TBBK TBC TCL TDOC TEAM TECK TEVA TFX TGT THC THMO TIDAL TIVO TISI TLRY TMO TMUS TNDM TNG TNK TORM TPIC TPRG TR TRC TRG TRIP TRMB TRN TROX TSCO TSE TSLA TSN TTD TTC TTWO TUSK TVTY TXN TXRH TYL U UAL UAN UBER UHAL ULTA UMC UNFI UNH UNIT UNM URBN USFD USI USNA UTHR V VAL VAR VBIV VCEL VCNX VCR VCSH VCTR VEC VECO VEL VEN VER VERU VFC VFH VHT VICR VIPS VIRC VRT VSH VSTM VTGN VTRS VTR VTWV VVNT VY W WAB WBA WDC WEC WELL WEN WERN WEX WFC WGO WHR WIA WMB WMT WNC WNR WPC WRB WST WTAI WTI WTW WU WY WYNN X XCEL XCUR XELA XOM XPER XPO XRAY XRO XRT XTL XYL YELL YETI YEXT YMM YNDX YRC YUM Z ZBH ZBRA ZGNX ZION ZLAT ZNH ZNTE ZOM ZRO ZSAN ZTO ZTS ZUO

New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

globenewswire.com
BIIB

New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

prnewswire.com
BIIB

Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer

prnewswire.com
BMN RPH RNOV BIIB